Clinical Trials Browser

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors

Clinical Trials

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

A First-in-Human Study of PRL3-ZUMAB

A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors

Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)

A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

GUARDIAN

SINGULARITY

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors

IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors

A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors

A Phase I Study of JS108 in Patients With Advanced Solid Tumors

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors

Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

CHITIN

Lapatinib and Bortezomib in Patients With Advanced Malignancies

Sorafenib Plus S-1 in Advanced Solid Tumors

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

Ixabepilone and Pemetrexed/Solid Tumors

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

BEL

A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors

Lenalidomide and Paclitaxel in Advanced Solid Tumors

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Satraplatin and Vinorelbine in Advanced Solid Tumors